Enterprise Value (EV): $28.79B
The enterprise value (EV) is $28.79B as of Friday, June 26, 2026.
DGX Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$28.79B
DGX Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $22.83B | $28.79B |
| BioNTech SE (BNTX)vs › | $22.76B | $14.31B |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | $20.03B |
| Moderna, Inc. (MRNA)vs › | $23.71B | $10.79B |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | $27.54B |
| Incyte Corporation (INCY)vs › | $21.48B | $16.25B |
| Waters Corporation (WAT)vs › | $24.57B | $23.51B |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | $31.01B |
| STERIS plc (STE)vs › | $20.52B | $23.36B |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | $32.05B |
Enterprise Value Calculation
Market Cap
$22.83B
Total Debt
$6.38B
Cash
$420.00M
Enterprise Value
$28.79B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Quest Diagnostics Incorporated (DGX)?
- The enterprise value (EV) for DGX stock is $28.79B.
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis